arrow
B

Bin-yong Liang

华中科技大学
H指数:19
被引数:1,207

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Online risk scores for pre- and postoperative prediction of early recurrence in hepatocellular carcinoma patients undergoing conversion liver resection after tyrosine kinase inhibitors and immune checkpoint inhibitors therapy

行转化性肝切除的肝细胞癌患者经酪氨酸激酶抑制剂和免疫检查点抑制剂治疗后,用于术前和术后早期复发的在线风险评分

2025-06-160
PRE
A combined pre- and intra-operative nomogram in evaluation of degrees of liver cirrhosis predicts post-hepatectomy liver failure: a multicenter prospective study
2024-04-011
OAAI
ß-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma
2022-08-0120
OA
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by -TGF antibody to promote durable rejection and immunity in squamous cell carcinomas

Α-pd-1治疗可提高Treg/Th平衡并增加肿瘤细胞pSmad3,这两者均被-TGF抗体靶向,以促进鳞状细胞癌的持久排斥和免疫力

2019-03-04144
OAAI